Clopicard Ap 75mg Tablet is a widely prescribed dual antiplatelet therapy (DAPT) used to prevent blood clots, reduce the risk of heart attack, stroke, and other atherothrombotic events in individuals with cardiovascular risk. This combination works by inhibiting platelet aggregation through two complementary pathways, offering enhanced protection against arterial thrombosis.

This fixed-dose combination is commonly recommended for:

• Patients after myocardial infarction (heart attack)

• Individuals who have undergone coronary angioplasty or stenting (PCI)

• Those with a history of ischemic stroke or transient ischemic attack (TIA)

• Patients with peripheral artery disease (PAD) or coronary artery disease (CAD)

• High-risk individuals with diabetes, hypertension, or dyslipidemia

Active Ingredients and Their Role:

• Aspirin 75 mg: A low-dose antiplatelet agent that inhibits thromboxane A2, preventing platelet clumping and reducing clot formation in arteries.

• Clopidogrel 75 mg: A P2Y12 receptor blocker that further prevents platelet activation and aggregation, enhancing blood flow and reducing the risk of clots.

Together, they form a standard therapy in cardiovascular prevention, especially after acute coronary syndrome (ACS) or stent placement, ensuring better long-term outcomes and survival rates.